These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31015574)

  • 1. Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1.
    He H; Song D; Sinha I; Hessling B; Li X; Haldosen LA; Zhao C
    Oncogene; 2019 Jul; 38(28):5725-5738. PubMed ID: 31015574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.
    Zhao C; Qiao Y; Jonsson P; Wang J; Xu L; Rouhi P; Sinha I; Cao Y; Williams C; Dahlman-Wright K
    Cancer Res; 2014 Jul; 74(14):3983-94. PubMed ID: 24830720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NRG1 regulates Fra-1 transcription and metastasis of triple-negative breast cancer cells via the c-Myc ubiquitination as manipulated by ERK1/2-mediated Fbxw7 phosphorylation.
    Shu L; Chen A; Li L; Yao L; He Y; Xu J; Gu W; Li Q; Wang K; Zhang T; Liu G
    Oncogene; 2022 Feb; 41(6):907-919. PubMed ID: 34992218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AP-1 Signaling by Fra-1 Directly Regulates HMGA1 Oncogene Transcription in Triple-Negative Breast Cancers.
    Tolza C; Bejjani F; Evanno E; Mahfoud S; Moquet-Torcy G; Gostan T; Maqbool MA; Kirsh O; Piechaczyk M; Jariel-Encontre I
    Mol Cancer Res; 2019 Oct; 17(10):1999-2014. PubMed ID: 31300541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor.
    Song D; He H; Sinha I; Hases L; Yan F; Archer A; Haldosen LA; Zhao C; Williams C
    Cancer Lett; 2021 May; 506():23-34. PubMed ID: 33652085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fra-1 regulates its target genes via binding to remote enhancers without exerting major control on chromatin architecture in triple negative breast cancers.
    Bejjani F; Tolza C; Boulanger M; Downes D; Romero R; Maqbool MA; Zine El Aabidine A; Andrau JC; Lebre S; Brehelin L; Parrinello H; Rohmer M; Kaoma T; Vallar L; Hughes JR; Zibara K; Lecellier CH; Piechaczyk M; Jariel-Encontre I
    Nucleic Acids Res; 2021 Mar; 49(5):2488-2508. PubMed ID: 33533919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells.
    Wang D; Huang J; Hu Z
    Mol Cell Proteomics; 2012 Feb; 11(2):M111.011932. PubMed ID: 22086602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia.
    Lin S; Tian L; Shen H; Gu Y; Li JL; Chen Z; Sun X; You MJ; Wu L
    Oncogene; 2013 Oct; 32(40):4845-53. PubMed ID: 23108395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction Proteomics Identifies ERbeta Association with Chromatin Repressive Complexes to Inhibit Cholesterol Biosynthesis and Exert An Oncosuppressive Role in Triple-negative Breast Cancer.
    Alexandrova E; Giurato G; Saggese P; Pecoraro G; Lamberti J; Ravo M; Rizzo F; Rocco D; Tarallo R; Nyman TA; Collina F; Cantile M; Di Bonito M; Botti G; Nassa G; Weisz A
    Mol Cell Proteomics; 2020 Feb; 19(2):245-260. PubMed ID: 31792072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor.
    Germann S; Gratadou L; Zonta E; Dardenne E; Gaudineau B; Fougère M; Samaan S; Dutertre M; Jauliac S; Auboeuf D
    Oncogene; 2012 Oct; 31(42):4536-49. PubMed ID: 22266867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms.
    Han BY; Liu Z; Hu X; Ling H
    Cell Death Dis; 2022 Nov; 13(11):940. PubMed ID: 36347834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX5 is a multifunctional co-activator of steroid hormone receptors.
    Wagner M; Rid R; Maier CJ; Maier RH; Laimer M; Hintner H; Bauer JW; Onder K
    Mol Cell Endocrinol; 2012 Sep; 361(1-2):80-91. PubMed ID: 22476084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
    Vial E; Marshall CJ
    J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer.
    Hashemi V; Masjedi A; Hazhir-Karzar B; Tanomand A; Shotorbani SS; Hojjat-Farsangi M; Ghalamfarsa G; Azizi G; Anvari E; Baradaran B; Jadidi-Niaragh F
    J Cell Physiol; 2019 May; 234(5):5478-5487. PubMed ID: 30417346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.
    He W; Wu Y; Tang X; Xia Y; He G; Min Z; Li C; Xiong S; Shi Z; Lu Y; Yuan Z
    Oncotarget; 2016 Feb; 7(6):6727-47. PubMed ID: 26734995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDX5 promotes hepatocellular carcinoma tumorigenesis via Akt signaling pathway.
    Xue Y; Jia X; Li L; Dong X; Ling J; Yuan J; Li Q
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2885-2891. PubMed ID: 30119889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
    Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
    J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.